Clinical Trial: Comparison of checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the neoadjuvant treatment of locally advanced pMMR/MSS colorectal cancer: a randomized, open-label, single-center phase II clinical study (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the neoadjuvant treatment of locally advanced pMMR/MSS colorectal cancer: a randomized, open-label, single-center phase II clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131038

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=287944

Published by HT Digital Content Services with permission from Health Daily Digest....